Dr. Giovannucci et El. Stuenkel, GLUTAMATE-RECEPTOR AGONISTS MODULATE [CA2+](I) IN ISOLATED RAT MELANOTROPES, Neuroendocrinology, 62(2), 1995, pp. 111-122
Although glutamate is the predominant excitatory amino acid in the ver
tebrate central nervous system (CNS) where it affects a variety of phy
siological processes and pathophysiological states, the role that glut
amate receptors may play Neurohypophysis outside the CNS has not been
clearly established. In the present study, the Intermediate lobe effec
ts of N-methyl-D-aspartate (NMDA), no-2,3-dihydro-5-methyl-3-oxo-4-iso
xazolepropanoic acid (AMPA) kainate, and metabotropic glutamate recept
or agonists and antagonists were investigated on neuroendocrine melano
tropes of the rat pars intermedia using single-cell dual-wavelength mi
crofluorometry and the Ca(2+)sensitive probe, fura-2, to monitor chang
es in [Ca2+](i). Glutamate induced a rapid, concentration-dependent ri
se in [Ca2+](i) with an EC(50) Of 24 mu M that was Mg2+-sensitive and
dependent on the presence of extracellular Ca2+. NMDA increased [Ca2+]
(i) in a glycine-dependent manner with an EC(50) of 83 mu M that was b
locked by 1 mu M MK-801 and 1 mM Mg2+. The non-NMDA receptor agonists
kainate, AMPA, and quisqualate increased [Ca2+](i) with an EC(50) Of 1
24, 5 and 8 mu M, respectively. Responses to kainic acid were blocked
by 10 mu M CNQX and were shown to be sensitive to Mg2+ and dihydropyri
dine. AMPA stimulation was the most potent, and glutamate stimulation
was the most efficacious at mediating increases in [Ca2+](i). The meta
botropic receptor-specific agonist, trans-ACPD, failed to induce a cha
nge in [Ca2+](i). The glutamate-induced Ca2+ influx was about half of
that elicited by a 50 mM K+-induced membrane depolarization and activa
tion of voltage-sensitive Ca2+ channels. These results demonstrate the
presence of glutamate receptors on rat melanotropes and suggest that
glutamate receptors in the intermediate lobe of the pituitary may prov
ide the excitatory counterbalance to the well-described secretoinhibit
ing input via dopamine and gamma-aminobutyric acid receptors.